Iovance Biotherapeutics (IOVA) had the highest return in February 2020 by a mid-cap US stock, returning 49.3%.
Iovance Biotherapeutics (IOVA) had the highest return in February 2020 by a mid-cap US stock, returning 49.3%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.